Rankin Aubrey Insider Trades

Insider Trading History

Track insider trading activity for Rankin Aubrey. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Revance Therapeutics
Revance Therapeutics RVNC
Director
Holding Value $343k 94,091 shares
Last Trade
Mar 15, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.7k 1,372 shares
$15.79
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $348k 95,463 shares
Last Trade
Dec 03, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$433k 30,000 shares
$14.43
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $239k 65,463 shares
Last Trade
Aug 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$247k 9,364 shares
$26.34
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $273k 74,827 shares
Last Trade
Aug 15, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$129k 4,949 shares
$26.02
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $1.17M 321,611 shares
Last Trade
Jul 28, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.63M 54,332 shares
$30.06
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $1.3M 355,943 shares
Last Trade
Jul 26, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.65M 55,382 shares
$29.72
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $1.5M 411,325 shares
Last Trade
Apr 05, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$56.6 2 shares
$28.28
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $1.5M 411,327 shares
Last Trade
Mar 04, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$842k 33,119 shares
$25.43
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $291k 79,776 shares
Last Trade
Feb 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$937k 33,445 shares
$28.01
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $1.62M 444,446 shares
Last Trade
Feb 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$859k 33,119 shares
$25.95
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $1.74M 477,565 shares
Last Trade
Dec 30, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$921k 33,119 shares
$27.82
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $1.86M 510,684 shares
Last Trade
Nov 30, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$790k 33,119 shares
$23.85
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $1.98M 543,803 shares
Last Trade
Oct 29, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$866k 33,119 shares
$26.15
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $2.11M 576,922 shares
Last Trade
Sep 28, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$867k 33,119 shares
$26.18
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $2.23M 610,041 shares
Last Trade
Jul 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7M 667,292 shares
$23.50
$3.65
Revance Therapeutics
Revance Therapeutics RVNC
President, Innovation & Tech
Holding Value $2.44M 667,292 shares
Last Trade
Jul 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.9M 720,987 shares
$23.50
$3.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up